Buy Cyclacel Pharmaceuticals Stock | CYCC Stock Price & Latest News | Public
CYCC

Cyclacel Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap

    About CYCC

    Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.93
    -1.87
    -2.8
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.56

    Actual EPS
    Q3 2020

    Stats

    Market Cap$18,19M
    Volume6,15k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$19.60
    1 Year Low$3.23
    Open$3.63
    High$3.75
    Low$3.54

    Buy any stock with any amount of money.

    Download the App
    Download the app